ATIM-15. A PHASE 1 STUDY OF Ad-RTS-hIL-12 + VELEDIMEX IN ADULTS WITH RECURRENT GLIOBLASTOMA: DOSE DETERMINATION WITH UPDATED OVERALL SURVIVAL-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ATIM-15. A PHASE 1 STUDY OF Ad-RTS-hIL-12 + VELEDIMEX IN ADULTS WITH RECURRENT GLIOBLASTOMA: DOSE DETERMINATION WITH UPDATED OVERALL SURVIVAL

Published:2018-11 Issue:suppl_6 Volume:20 Page:vi3-vi4
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Chiocca E Antonio¹,Lukas Rimas²,Yu John³,Oberheim Bush Nancy Ann⁴,Buck Jill⁵,Demars Nathan⁵,Barrett John⁵,Gelb Arnold⁵,Wang Yunxia⁵,Cooper Laurence⁵,Lebel Francois⁵

Affiliation:

1. Department of Neurosurgery, Brigham and Womens Hospital, Boston MA, Boston, MA, USA

2. Northwestern University Feinberg School of Medicine, Chicago, IL, USA

3. Cedars-Sinai, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA

4. University of California, San Francisco, San Francisco, CA, USA

5. Ziopharm Oncology, Inc, Boston, MA, USA

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/20/suppl_6/vi3/26279607/noy148.010.pdf

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical trials using oncolytic viral therapy to treat adult glioblastoma: a progress report;Neurosurgical Focus;2021-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP